Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04981821

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

A Pilot Randomized Trial of a Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
170 (estimated)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.

Detailed description

Up to 98% of older patients with myeloid neoplasms experience physical function decline, fatigue, and mood disturbances. Mobile health exercise interventions are promising strategy to prevent physical function decline and improve fatigue and mood disturbances, but older patients with myeloid neoplasms receiving outpatient chemotherapy are understudied. The proposed study will investigate whether a novel mobile health exercise intervention that is adapted to this population can prevent physical function decline, improve fatigue and mood disturbances, and prevent worsening quality of life.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGO-EXCAP Mobile AppA mobile app delivery platform to deliver an exercise program \[Exercise for Cancer Patients (EXCAP©®)\]. EXCAP©®) is a progressive walking and resistance exercise program
BEHAVIORALBehavioral Placebo ControlParticipants will meet with an oncology nurse (for approximately 60 min) to review the NCI booklet Chemotherapy and You: Support for People With Cancer, which includes facts about chemotherapy and its side effects. They will be provided with NCI online resources to review at home.

Timeline

Start date
2022-01-03
Primary completion
2026-06-30
Completion
2026-12-31
First posted
2021-07-29
Last updated
2026-04-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04981821. Inclusion in this directory is not an endorsement.